Angiotensin III-induced modulation of neurogenic responses in the rabbit vas deferens and portal vein
- 1 January 1984
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 326 (4) , 327-333
- https://doi.org/10.1007/bf00501437
Abstract
The effects of prostaglandin synthesis inhibitors on the presynaptic actions of angiotensin (ang) II and III were examined in isolated rabbit vasa deferentia and portal veins. Ang II caused dose-dependent potentiation of low frequency, nerve stimulation in vasa deferentia and portal vein. Indomethacin (26 μM) enhanced the electrically-induced contractions in the vasa deferentia only but did not alter the potency of ang II in either preparation. In contrast, ang II decreased contractions in vasa deferentia induced by nerve stimulation by up to 36% (10−6 M) and potentiated these contractions at concentrations higher than 10−6 M. The inhibitory action of ang III on vasa deferentia was converted to potentiation by pretreatment with indomethacin or mepacrine. Exogenous PGE2 blocked low frequency nerve stimulation and not responses to norepinephrine. This prostaglandin appeared to mimic ang III in the vas deferens. No effects of ang III were observed if the contractions were induced by exogenous alpha adrenergic agonists. [Sar1, Ala8] and II antagonized all responses to the angiotensins, whereas [Sar1, Cys-CH3 8] ang II selectively antagonized the angiotensin-induced potentiation. Responses in field-stimulated portal veins were potentiated by ang III and this response was unaffected by indomethacin. This investigation strongly suggests the existence of at least two ang receptors in the vas deferens and demonstrates for the first time selective responses to the octa- and heptapeptides in the same effector organ.This publication has 24 references indexed in Scilit:
- A Potent Noncompetitive Angiotensin II Antagonist Induces Only Competitive Inhibition of Angiotensin III ResponsesJournal of Cardiovascular Pharmacology, 1983
- Prostacyclin (PGI2) release accompanying angiotensin conversion in rat mesenteric vasculatureEuropean Journal of Pharmacology, 1981
- A possible antihypertensive mechanism of propranolol: antagonism of angiotensin II enhancement of sympathetic nerve transmission through prostaglandins.Hypertension, 1981
- Angiotensin II Stimulation of Renal Prostaglandin Synthesis Elevates Circulating Prostacyclin in the DogJournal of Cardiovascular Pharmacology, 1980
- In vitro neurogenic and musculotropic responses to angiotensin peptides in normal and sodium-restricted rabbits.Circulation Research, 1980
- Synthesis and pharmacology of a noncompetitive antagonist of angiotensin-induced contractions of vascular smooth muscle. [Sarcosyl]1-[cysteinyl (s-methyl)]8-angiotensin II.Circulation Research, 1980
- Effects of prostacyclin (PGI2), 6-oxo-PGF1 alpha and PGE2 on sympathetic nerve function in mesenteric arteries and veins of the rabbit in vitro.Hypertension, 1979
- Characterization of receptors for angiotensin in the rat vas deferensCanadian Journal of Physiology and Pharmacology, 1979
- Angiotensin II Stimulation of Prostaglandin Production in Cultured Human Vascular EndotheliumScience, 1975
- Modulating Effect of Prostaglandin E2 on Noradrenaline Release from the Isolated Cat SpleenActa Physiologica Scandinavica, 1969